AL
Alector, Inc.
ALEC · NASDAQ
$2.04 -7.08% (-$0.15)
1M -0.49%
Market Cap $225.9M
P/E Ratio -
Div. Yield -
ROE 531.04%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 16.30x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 47.72%
Rev. growth 46.00%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 914.56%
Gross margin 360.92%
FCF margin 1,142.55%
Quality
1 /100
Poor ROA 58.10%
ROIC 67.73%
Asset turnover 0.07x
Debt
100 /100
Low Current ratio 5.26x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
53 /100
Moderate EPS volatility 17.08%
Beta 0.58x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALEC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Arnon Rosenthal
Employees
103
Headquarters
South San Francisco
Upcoming events
05 NOV
Earnings
Upcoming earnings report